Line 55: |
Line 55: |
| 2. '''Reduce Afterload | | 2. '''Reduce Afterload |
| ::Vasodilators to decrease systemic vascular resistance | | ::Vasodilators to decrease systemic vascular resistance |
− | :::ACE inhibitors e.g. Enalapril, Benzapril, Imidopril , | + | :::ACE inhibitors e.g. Enalapril, Benzapril, Imidopril |
| :::Pimobendan | | :::Pimobendan |
| :::Calcium channel blockers e.g. Amlodipine | | :::Calcium channel blockers e.g. Amlodipine |
| :::Nitrates e.g. Nitroprusside | | :::Nitrates e.g. Nitroprusside |
| 3. '''Enhance Systolic function | | 3. '''Enhance Systolic function |
− | ::Positive Inotropes to increase cardiac contractility and increase cardiac output. | + | ::Positive inotropes to increase cardiac contractility and increase cardiac output (Pimobendan, Digoxin, Dobutamine, Xanthines) |
− | :::Pimobendan
| |
− | :::Digoxin
| |
− | :::Dobutamine
| |
− | :::Xanthines
| |
| 4. '''Improve Diastolic function | | 4. '''Improve Diastolic function |
− | ::Negative Chronotropes to increase the length of diastole (digoxin, atenolol) | + | ::Negative chronotropes to increase the length of diastole (Digoxin, Atenolol) |
− | ::Calcium channel blockers to improve relaxation (amlodipine) | + | ::Calcium channel blockers to improve relaxation (Amlodipine) |
| 5. '''Control cardiac arrhythmias using anti-arrhythmic drugs | | 5. '''Control cardiac arrhythmias using anti-arrhythmic drugs |
| | | |